Pluri Inc. (PLUR): Revenue
$1.02M
Year ended 2026-06-30
+52.4%
3-year compound annual growth
-9.8%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.02M | -24.0% | 2026-09-10, From 2025-07-01 |
| 2025-06-30 | $1.34M | +309.8% | 2026-09-10, From 2024-07-01 |
| 2024-06-30 | $326.0K | +13.6% | 2025-09-17, From 2023-07-01 |
| 2023-06-30 | $287.0K | +22.6% | 2024-09-18, From 2022-07-01 |
| 2022-06-30 | $234.0K | n/a | 2023-09-12, From 2021-07-01 |
| No annual figure between 2020-06-30 and 2022-06-30. | |||
| 2020-06-30 | $23.0K | -57.4% | 2021-09-13, From 2019-07-01 |
| 2019-06-30 | $54.0K | +8.0% | 2020-09-10, From 2018-07-01 |
| 2018-06-30 | $50.0K | n/a | 2020-09-10, From 2017-07-01 |
| No annual figure between 2016-06-30 and 2018-06-30. | |||
| 2016-06-30 | $2.85M | +651.2% | 2018-09-12, From 2015-07-01 |
| 2015-06-30 | $379.0K | 0.0% | 2017-09-07, From 2014-07-01 |
| 2014-06-30 | $379.0K | -44.2% | 2016-09-07, From 2013-07-01 |
| 2013-06-30 | $679.0K | -5.2% | 2015-09-09, From 2012-07-01 |
| 2012-06-30 | $716.0K | n/a | 2014-09-11, From 2011-07-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Pluri Inc. (PLUR) | 2026-06-30 | $1.02M | -24.0% |
| Prokidney Corp. (PROK) | 2025-12-31 | $893.0K | n/m |
| ImageneBio, Inc. (IMA) | 2025-12-31 | $800.0K | -77.1% |
| Inhibrx Biosciences, Inc. (INBX) | 2025-12-31 | $1.30M | +550.0% |
| Scinai Immunotherapeutics Ltd. (SCNI) | 2025-12-31 | $1.31M | +99.2% |
| Outlook Therapeutics, Inc. (OTLK) | 2025-09-30 | $1.41M | n/a |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | $593.0K | -13.2% |
| Humacyte, Inc. (HUMA) | 2025-12-31 | $2.04M | n/a |
| Aligos Therapeutics, Inc. (ALGS) | 2025-12-31 | $2.19M | -39.5% |
Compare PLUR, PROK, IMA, INBX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗